2 completed, 1 enrolling by invitation, 1 terminated. 4 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Enrolling by invitation 1, Terminated 1 |
| Phase 1 | 2 | Completed 1, Enrolling by invitation 1 |
| Phase 3 | 1 | Completed 1 |
Follow Liver Cirrhoses: new trials by email Literature Review of Liver Cirrhoses trials Research Report on Liver Cirrhoses
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of the Combination of Simvastatin Plus Rifaximin in Patients With Decompensated Cirrhosis to Prevent ACLF Development Simvastatin, Rifaximin, Placebo of Simvastatin - Liver Cirrhoses | Phase 2 / Phase 3 | Completed | Judit Pich | 254 | 2019-01-03 | 2023-05-24 |
| Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence Pravastatin Pill, Placebo Oral Tablet - Hepatocellular Carcinoma, Liver Cirrhoses | Phase 2 | Terminated | Cedars-Sinai Medical Center | 1 | 2018-09-27 | 2021-01-22 |
| Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis PRI-724 - Hepatitis C, Hepatitis B | Phase 1 / Phase 2 | Completed | Kiminori Kimura, MD | 27 | 2018-07-24 | 2024-10-10 |
| Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B Allogeneic Umbilical Cord Mesenchymal Stem Cell - Liver Cirrhoses | Phase 1 / Phase 2 | Enrolling by invitation | PT. Prodia Stem Cell Indonesia | 12 | 2018-05-17 | 2026-02-25 |
Carcinoma, Hepatocellular (1) · Hepatitis B (1) · Hepatitis C (1) · Liver Cirrhosis (1)
Digestive System Diseases (2) · Liver Diseases (2) · Adenocarcinoma (1) · Blood-Borne Infections (1) · Carcinoma (1) · Communicable Diseases (1) · DNA Virus Infections (1) · Digestive System Neoplasms (1) · Fibrosis (1) · Flaviviridae Infections (1) · Hepadnaviridae Infections (1) · Hepatitis (1) · Hepatitis, Viral, Human (1) · Infections (1) · Liver Neoplasms (1)
Hydroxymethylglutaryl-CoA Reductase Inhibitors (1) · ICG 001 (1) · Pravastatin (1) · Rifaximin (1) · Simvastatin (1)
Cedars-Sinai Medical Center (1) · Judit Pich (1) · Kiminori Kimura, MD (1) · PT. Prodia Stem Cell Indonesia (1)
Belgium (1) · France (1) · Germany (1) · Indonesia (1) · Italy (1) · Japan (1) · Netherlands (1) · Spain (1) · United Kingdom (1) · United States (1)
Chyntia O Jasirwan, PhD (1) · Kiminori Kimura, MD (1) · Rima Haifa, B.Sc (1) · Shehnaz Hussain, PhD (1)
PMID 33654016, PMID 35605429, PMID 39908052
R01CA218486 (1)